Capricor Therapeutics(US:CAPR) Seeking Alpha·2026-01-10 09:12Core Insights - The Biotech Forum facilitates discussions on specific covered call trades and offers a model portfolio of attractive biotech stocks [1] - Bret Jensen, with over 13 years of experience as a market analyst, leads The Biotech Forum, focusing on high beta sectors with significant potential returns [2] Group 1 - The Biotech Forum provides a model portfolio featuring 12-20 high upside biotech stocks, along with live chat for trade discussions and weekly research updates [2] - The group offers market commentary and portfolio updates every weekend, enhancing investor engagement and information flow [2] Group 2 - The analyst has a beneficial long position in CAPR shares, indicating a personal investment interest in the stock [3] - The article expresses the analyst's opinions without external compensation, emphasizing independence in analysis [3]